PharmacoEconomics & Outcomes News 463 - 9 Oct 2004 ■ Eli Lilly has been awarded programme design certification for five disease management (DM) programmes by the US National Committee for Quality Assurance (NCQA). The certification provides third-party confirmation that a DM programme is welldesigned, effective and patient-friendly. Lilly’s DM programmes, which include four diabetes mellitus interventions and a comprehensive online healtheducation intervention, were reviewed primarily for their content and consistency with national practice guidelines. "Our goal is to reduce patient risk, help the healthcare system achieve the highest level of performance and create an environment of continuous improvement", says vice president of Lilly’s Businessto-Business division Jack Bailey. Eli Lilly and Company. Lilly Receives NCQA Certification for Five Disease Management Programs. Media Release : 22 Sep 2004. Available from: URL: 809039536 http://www.lilly.com

1173-5503/10/0463-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

PharmacoEconomics & Outcomes News 9 Oct 2004 No. 463

1